Y Uehara

1.0k total citations
23 papers, 889 citations indexed

About

Y Uehara is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Y Uehara has authored 23 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Y Uehara's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Y Uehara is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Y Uehara collaborates with scholars based in Japan, United States and Malaysia. Y Uehara's co-authors include Satoshi Mizuno, H Fukazawa, Yuko Murakami, Y. Sugimoto, Y Kaziro, Takaya Satoh, Satoshi Mizuno, K J Einspahr, Robert T. Abraham and Bryce A. Binstadt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Y Uehara

23 papers receiving 857 citations

Peers

Y Uehara
P M Blumberg United States
Murray McKinnon United States
Janey N. Parsons United States
Klaus Fuchs Germany
Eric S. Day United States
Doris N. Savoy United States
Paul Rose United States
P A Marks United States
Y Uehara
Citations per year, relative to Y Uehara Y Uehara (= 1×) peers Arsenio Nueda

Countries citing papers authored by Y Uehara

Since Specialization
Citations

This map shows the geographic impact of Y Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Uehara more than expected).

Fields of papers citing papers by Y Uehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Uehara. The network helps show where Y Uehara may publish in the future.

Co-authorship network of co-authors of Y Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Y Uehara. A scholar is included among the top collaborators of Y Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Uehara. Y Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niimi, Kyoko, Brian C. Monk, Asuka Hirai, et al.. (2010). Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity. Journal of Antimicrobial Chemotherapy. 65(5). 842–852. 36 indexed citations
2.
Hori, Hidetaka, Yasuhiro Igarashi, Takayuki Kajiura, et al.. (1998). ChemInform Abstract: Signal Transduction Inhibitors, Hibarimicins A, B, C, D, and G Produced by Microbispora. Part 2. Structural Studies.. ChemInform. 29(39). 3 indexed citations
3.
Fukazawa, H, Satoshi Mizuno, & Y Uehara. (1995). A Microplate Assay for Quantitation of Anchorage-Independent Growth of Transformed Cells. Analytical Biochemistry. 228(1). 83–90. 101 indexed citations
4.
Li, Pei-Ming, H Fukazawa, Shinichi Mizuno, & Y Uehara. (1994). Evaluation of protein kinase inhibitors in an assay system containing multiple protein kinase activities.. PubMed. 13(6A). 1957–64. 20 indexed citations
5.
Murakami, Yuko, H Fukazawa, Satoshi Mizuno, & Y Uehara. (1994). Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor. Biochemical Journal. 301(1). 57–62. 21 indexed citations
6.
Yoneda, Toshiyuki, Carolyn Lowe, Chul‐Ho Lee, et al.. (1993). Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.. Journal of Clinical Investigation. 91(6). 2791–2795. 76 indexed citations
7.
8.
Kanbe, T, et al.. (1993). Distinct Effects of Clinically Used Anthracycline Antibiotics on ras Oncogene-Expressed Cells.. Biological and Pharmaceutical Bulletin. 16(9). 908–911. 7 indexed citations
9.
Li, Pei-Ming, H Fukazawa, Chii Yamamoto, et al.. (1993). Method of identifying inhibitors of oncogenic transformation: selective inhibition of cell growth in serum-free medium.. PubMed. 8(7). 1731–5. 18 indexed citations
10.
Satoh, Takaya, Y Uehara, & Y Kaziro. (1992). Inhibition of interleukin 3 and granulocyte-macrophage colony-stimulating factor stimulated increase of active ras.GTP by herbimycin A, a specific inhibitor of tyrosine kinases.. Journal of Biological Chemistry. 267(4). 2537–2541. 69 indexed citations
11.
Mizuguchi, Junichiro, Yuji Yamanashi, Toru Tamura, et al.. (1992). Tyrosine protein kinase is involved in anti-IgM-mediated signaling in BAL17 B lymphoma cells. The Journal of Immunology. 148(3). 689–694. 27 indexed citations
12.
Kondo, Kazuhiro, Toshio Watanabe, Hiroshi Sasaki, Y Uehara, & M Oishi. (1989). Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.. The Journal of Cell Biology. 109(1). 285–293. 37 indexed citations
13.
Uehara, Y, Yuko Murakami, Y. Sugimoto, & Satoshi Mizuno. (1989). Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.. PubMed. 49(4). 780–5. 114 indexed citations
14.
Murakami, Yoshiaki, Satoshi Mizuno, Makoto Hori, & Y Uehara. (1988). Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.. PubMed. 48(6). 1587–90. 49 indexed citations
15.
Yoshioka, Akira, Osamu Nakagawa, Y Uehara, et al.. (1987). In vitro characterization of various heat-treated prothrombin complex concentrates(PCC). Thrombosis Research. 47(4). 449–458. 8 indexed citations
17.
Matsumoto, I., et al.. (1983). Immunochemical and Spectral Studies on Vicia faba Agglutinin. The Journal of Biochemistry. 93(3). 763–769. 19 indexed citations
18.
Fisher, Joyce M., et al.. (1983). Evidence for a membrane sulfhydryl associated with resistance to melphalan in a murine L1210 leukemia line. Biochemical and Biophysical Research Communications. 117(3). 670–676. 5 indexed citations
19.
Uehara, Y, Joyce M. Fisher, & M. Rabinovitz. (1980). Showdomycin and its reactive moiety, maleimide. Biochemical Pharmacology. 29(16). 2199–2204. 19 indexed citations
20.
Sakai, Tatsuo, Y Uehara, & Mitsuo Matsuka. (1974). The effect of temperature and other factors on the expression of elytral pattern in lady beetle, Harmonia axyridis Pallas.. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026